A model for multiple subcutaneous insulin injections developed from individual diabetic patient data.

Many diabetic patients taking multiple subcutaneous insulin injections cannot adjust their dosage appropriately to maintain blood glucose within a normal range. It is hard to predict how dosage changes and physiological fluctuations affect insulin levels and subsequently glucose control. To examine these issues, we have developed a model representing the link between dosage and blood insulin levels. Our model adequately predicts insulin concentrations for individual patients and could be incorporated into an overall glucose-insulin representation. More importantly, parameter and sensitivity analysis results highlight insulin kinetic features that are difficult to isolate in a clinical setting and that may significantly influence glucose dynamics. For example, large interpatient variation, measured quantitatively by model parameters, emphasizes the need for individualized design of insulin regimens. Intrapatient variations are also large in some patients. Improved control for these patients may only be possible through more frequent sampling and control action. The sensitivity coefficient for absorption suggests a significant overlapping injection effect that is not considered in present patient management strategies.

[1]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[2]  B. Zinman,et al.  The Role of Insulin in the Metabolic Response to Exercise in Diabetic Man , 1979, Diabetes.

[3]  A H Clemens,et al.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. , 1980, The New England journal of medicine.

[4]  P. Halban,et al.  The Effect of Aprotinin on the Absorption of Subcutaneously Injected Regular Insulin in Normal Subjects , 1980, Diabetes.

[5]  P. Felig,et al.  Alterations in Insulin Absorption and in Blood Glucose Control Associated with Varying Insulin Injection Sites in Diabetic Patients , 1980, Annals of Internal Medicine.

[6]  V. Jörgens,et al.  Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations , 1982, Diabetes Care.

[7]  T. Kobayashi,et al.  The Pharmacokinetics of Insulin After Continuous Subcutaneous Infusion or Bolus Subcutaneous Injection in Diabetic Patients , 1983, Diabetes.

[8]  W. E. Stewart,et al.  Sensitivity analysis of initial value problems with mixed odes and algebraic equations , 1985 .

[9]  G. King,et al.  Receptor-mediated transport of insulin across endothelial cells. , 1985, Science.

[10]  B. Feldt-Rasmussen,et al.  Kinetic models for insulin disappearance from plasma in type I diabetic patients. , 1987, Pharmacology & toxicology.

[11]  W. Duckworth Insulin degradation: mechanisms, products, and significance. , 1988, Endocrine reviews.

[12]  R. Süverkrüp,et al.  Numerical stability of pharmacokinetic deconvolution algorithms. , 1989, Journal of pharmaceutical sciences.